Clinical Trial Update: Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessed the safety and efficacy of carboxymethylcellulose ophthalmic solution for maintaining ocular surface integrity in symptomatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Keratoconjunctivitis Sicca

Drugs mentioned

• Carboxymethylcellulose ophthalmic solution (carboxymethylcellulose)

Snippet

Sponsor: Allergan | Conditions: Dry Eye Syndromes, Keratoconjunctivitis Sicca | Phase 4 | Status: COMPLETED | Results posted: 2011-09-21